GLP-3 (Retatrutide Analog) 30mg represents a higher-capacity research formulation for comprehensive preclinical studies of incretin receptor cross-talk and synergistic signaling mechanisms. Designed for extended laboratory protocols and multi-arm experimental designs.

Chemical Compound Information:

• Chemical Name: Retatrutide analog (triple receptor agonist at GLP-1/GIP/GCG)
• Molecular Formula: Polypeptide with complex tertiary structure
• Molecular Weight: Approximately 4,400 Da
• Compound Class: Synthetic peptide; multi-target incretin modulator

Description:
This 30mg preparation supplies sufficient material for comprehensive dose-response characterization across multiple preclinical model systems. The quantity supports both acute mechanistic studies and chronic dosing regimens in laboratory animal research protocols.

Research Applications:

• Comprehensive dose-escalation studies examining receptor saturation kinetics
• Investigation of synergistic pathway activation in isolated islet tissue preparations
• Evaluation of peptide distribution and retention in tissue-specific delivery models
• Assessment of long-term receptor adaptation and desensitization in animal models
• Study of metabolic endpoint changes in controlled diet and activity-monitored research systems

Storage and Handling:

• Store powder at -20°C in tightly sealed amber vials with desiccant canisters
• Use sterile, pyrogen-free water or appropriate buffer solutions for reconstitution
• Prepared stock solutions remain stable at 4°C for up to 48 hours maximum
• Minimize freeze-thaw cycles; utilize single-use aliquoted preparations when possible

Product Specifications:

• Purity: >98.5% as determined by reverse-phase HPLC
• Form: Lyophilized powder
• Quantity: 30mg per container
• Appearance: White to slightly off-white fine powder

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.